egfr and pd-l1 testing in locally advanced nsclc
Published 5 years ago • 353 plays • Length 7:46Download video MP4
Download video MP3
Similar videos
-
10:20
pd-l1 testing in advanced lung cancer
-
5:47
pd-l1 testing in metastatic nsclc
-
9:30
egfr testing for nsclc
-
1:10
dr. gubens on prevalence of egfr/alk/ros1 and pd-l1 expression in nsclc
-
8:25
egfr & alk/ros1 testing in squamous nsclc
-
1:44
pd-l1 testing in first-line treatment of nsclc
-
7:09
pd-l1 testing in squamous nsclc
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
4:14
case based panel discussion - egfr and high pdl1 what is the role of immunotherapy in treatment?
-
5:44
reliability of pd-l1 testing in nsclc
-
7:07
mutation testing in nsclc
-
6:31
locally advanced nsclc and treatment decisions
-
4:41
pd-l1 testing for nsclc
-
3:50
pd-l1 expression in nsclc
-
1:55
dr. hirsch on value of pd-l1 testing in patients with lung cancer
-
4:27
analysis of impassion130: pd-l1 testing in advanced tnbc
-
5:00
case 2: testing for egfr in lung adenocarcinoma
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
1:52
egfr-mutant lung cancer cells have a unique response to anti-pd-l1 antibodies